World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 April 2021
Main ID:  NCT03584841
Date of registration: 27/05/2018
Prospective Registration: No
Primary sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Public title: Implementation of a Non-invasive Version of the Imaging ß-adrenergic-dependent Sweat Secretion Test BUBBLE TEST
Scientific title: Implementation of a Non-invasive Version of the Imaging ß-adrenergic-dependent Sweat Secretion Test: Value for Diagnosis and Efficacy of Target Therapies for Cystic Fibrosis
Date of first enrolment: March 31, 2017
Target sample size: 120
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03584841
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Belgium
Contacts
Name:     Teresinha LEAL, Biologist
Address: 
Telephone: 00 32 2 764
Email: teresinha.leal@uclouvain.be
Affiliation: 
Name:     Teresinha LEAL, Biologist
Address: 
Telephone: 00 32 2 764
Email: teresinha.leal@uclouvain.be
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- For patients with cystic fibrosis: clinically stable, all genotypes included.

- For healthy volunteer and heterozygous subjects: 18 years and older.

Exclusion Criteria:

- Corticosteroids, anti-leukotriene therapy, unstable clinical status, <40% FEV1.

- Current pregnancy or breastfeeding.



Age minimum: 18 Years
Age maximum: 100 Years
Gender: All
Health Condition(s) or Problem(s) studied
Mucoviscidosis Involving the Lung
Intervention(s)
Diagnostic Test: Iontophoresis sessions in forearm of subjects with pilocarpine
Primary Outcome(s)
Ratio between the ß-adrenergic/cholinergic rate [Time Frame: up to 30 minutes]
Secondary Outcome(s)
Secondary ID(s)
2015/04MAI/231
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history